Increased mortality from complications of pulmonary hypertension in patients undergoing transcatheter aortic valve replacement.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28597767)

Published in Pulm Circ on May 12, 2017

Authors

Raj Parikh1, Benson Varghese2, Huma N Khatoon3, Julie A Kovach3, Clifford J Kavinsky3, Rajive Tandon2

Author Affiliations

1: 1 Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
2: 2 Division of Pulmonary and Critical Care, Rush University Medical Center, Chicago, IL, USA.
3: 3 Division of Cardiology, Rush University Medical Center, Chicago, IL, USA.

Articles cited by this

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 7.41

Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med (2016) 6.95

Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27

Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 5.88

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47

Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation (2006) 3.94

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation (2010) 2.32

Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol (2004) 2.20

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72

Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg (2007) 1.58

Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry. Circ Cardiovasc Interv (2014) 1.55

Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg (2011) 1.41

Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol (2000) 1.28

Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol (2015) 1.13

Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol (2012) 1.09

Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol (2011) 1.07

Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol (2008) 1.05

Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol (2000) 1.03

Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv (2009) 0.95

Pulmonary hypertension in isolated aortic stenosis. Hemodynamic correlations and follow-up. J Thorac Cardiovasc Surg (1988) 0.91

E/Ea is the major determinant of pulmonary artery pressure in moderate to severe aortic stenosis. J Am Soc Echocardiogr (2008) 0.88

Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism. Am Heart J (1993) 0.86

Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis. Eur J Echocardiogr (2008) 0.84

A review of most relevant complications of transcatheter aortic valve implantation. ISRN Cardiol (2013) 0.84

Frequency, determinants and outcome of pulmonary hypertension in patients with aortic valve stenosis. Am J Med Sci (2012) 0.83

Cardiac conduction system disease after transcatheter aortic valve replacement. Am Heart J (2012) 0.81

Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. Heart (2015) 0.78

Association of hyponatremia and outcomes in pulmonary hypertension. J Card Fail (2013) 0.77